TrialHepatology communications2026

Improvement in health-related quality of life after treatment with resmetirom in patients with the spectrum of MASLD: From early MASH to MASH cirrhosis.

Zobair M Younossi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.